These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5320454)

  • 1. Studies on the antimalarial effects of cycloguanil pamoate (CI-501) in man.
    Powell RD; DeGowin RL; Eppes RB
    Am J Trop Med Hyg; 1965 Nov; 14(6):913-21. PubMed ID: 5320454
    [No Abstract]   [Full Text] [Related]  

  • 2. The urinary excretion and the antimalarial activity of CI-501 (cycloguanil-pamoate, Camolar) against vivax and falciparum malaria.
    Contacos PG; Coatney GR; Lunn JS; Chin W
    Am J Trop Med Hyg; 1966 May; 15(3):281-6. PubMed ID: 5328125
    [No Abstract]   [Full Text] [Related]  

  • 3. [The proper use of antimalarial drugs currently available].
    Bourgeade A; Delmont J
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):493-6. PubMed ID: 10078393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of cycloguanil pamoate (CI-501) against a chlorguanide-resistant Chesson strain of Plasmodium vivax.
    Chin W; Lunn JS; Buxbaum J; Contacos PG
    Am J Trop Med Hyg; 1965 Nov; 14(6):922-4. PubMed ID: 5320455
    [No Abstract]   [Full Text] [Related]  

  • 5. [In vitro sensitivity of Plasmodium falciparum isolates from Gabon to chloroquine and cycloguanil].
    Pradines B; Mabika Mamfoumbi M; Keundjian A; Lebeau C; Fusai T; Owono Medang M; Rogier C; Parzy D; Kombila M
    Bull Soc Pathol Exot; 1999 May; 92(2):91-4. PubMed ID: 10399596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
    Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some pharmacological aspects of antimalarial drugs.
    Botha D
    S Afr Med J; 1974 Jun; 48(29):1263-5. PubMed ID: 4607434
    [No Abstract]   [Full Text] [Related]  

  • 8. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
    Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Noviyanti R; Kenangalem E; Poespoprodjo JR; Burgess SJ; Peyton DH; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5721-6. PubMed ID: 26149984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to cycloguanil pamoate (CI-501) by falciparum malaria in West Pakistan.
    Contacos PG; Coatney GR; Lunn JS; Chin W
    Am J Trop Med Hyg; 1965 Nov; 14(6):925-6. PubMed ID: 5320456
    [No Abstract]   [Full Text] [Related]  

  • 11. A statistical analysis of the antimalarial activity of proguanil and cycloguanil in human volunteers.
    Yeo AE; Edstein MD; Shanks GD; Rieckmann KH
    Ann Trop Med Parasitol; 1994 Dec; 88(6):587-94. PubMed ID: 7893172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects of antimalarial prophylactic drugs: an important consideration in the risk-benefit equation.
    Davis TM
    Ann Pharmacother; 1998 Oct; 32(10):1104-6. PubMed ID: 9793605
    [No Abstract]   [Full Text] [Related]  

  • 13. Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil.
    Kaneko A; Bergqvist Y; Takechi M; Kalkoa M; Kaneko O; Kobayakawa T; Ishizaki T; Björkman A
    J Infect Dis; 1999 Apr; 179(4):974-9. PubMed ID: 10068594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
    Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
    Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro.
    Watkins WM; Sixsmith DG; Chulay JD
    Ann Trop Med Parasitol; 1984 Jun; 78(3):273-8. PubMed ID: 6385887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant resistance to pyrimethamine and cycloguanil of chloroquine-resistant falciparum malaria from East Africa: an in vitro study of 12 isolates.
    Schapira A
    Trans R Soc Trop Med Hyg; 1984; 78(3):359-62. PubMed ID: 6380024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroquine resistant malaria in children.
    Memon IA; Kanth N; Murtaza G
    J Pak Med Assoc; 1998 Apr; 48(4):98-100. PubMed ID: 9783043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia.
    Fryauff DJ; Sumawinata I; Purnomo ; Richie TL; Tjitra E; Bangs MJ; Kadir A; Ingkokusumo G
    Am J Trop Med Hyg; 1999 Apr; 60(4):542-6. PubMed ID: 10348226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone) and chloroquine.
    Enosse S; Butcher GA; Margos G; Mendoza J; Sinden RE; Høgh B
    Trans R Soc Trop Med Hyg; 2000; 94(1):77-82. PubMed ID: 10748906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.